Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 16, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Jul. 16, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 18, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Jun. 18, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...Stoke Therapeutics to Present at Upcoming Investor Conferences in June
June 3, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Jun. 3, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated t ...Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 17, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--May 17, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated t ...Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
May 6, 2024
– Recent data demonstrating reductions in seizure frequency and improvements in cognition and behavior support the potential ...Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
April 29, 2024
– Mr. Leggett brings more than two decades of experience as an investment banker and corporate executive leading financial st ...Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
April 17, 2024
– Mr. Hoitt brings more than two decades of successful commercial experience with an emphasis on rare diseases – BEDFORD, Mas ...Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 4, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Apr. 4, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated t ...Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
March 27, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Mar. 27, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...Stoke Therapeutics Announces Proposed Public Offering
March 26, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Mar. 26, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...